Novavax, Inc. is a clinical-stage vaccine company headquartered in Gaithersburg, Maryland with additional facilities in Rockville, Maryland and Uppsala, Sweden. Novavax is a public company that trades under the symbol "NVAX". - Source: Wikipedia
Novavax, however, says that ”no human fetal-derived cell lines or tissue” were used in the development, manufacture or production of its vaccine.
"While we're pleased with the initial utilization of our vaccine, we expect to see additional pull-through within these markets in the coming months as demand continues with recent surges in COVID around the world," Novavax said in a written statement.
© Copyright 2022 The Washington Times, LLC
3600 New York Avenue NE, Washington, DC 20002